Addiction Medicine
Stanford study will test antidepressant patch that may help smokers kick the habit
Published in Physician Law Weekly, February 7th, 2007
Researchers at the Stanford Prevention Research Center are looking for regular smokers to try a skin patch that delivers a medication used to treat depression. The drug, selegiline, could help smokers combat the cravings they feel when they try to quit, said study leader Joel Killen, PhD, professor of medicine.
The medication, which is marketed under the name Emsam, is produced by Somerset Pharmaceuticals and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2007-02-07)
More Articles from Physician Law Weekly
- Addiction Medicine
Findings from Center for Addiction and Mental Health broaden understanding of addiction medicine - Antibacterial Agents
Patents of leading antibiotics expire, will constrain the antibacterial market - Anxiety Disorders Quality of Care
Research from National Institute on Alcohol Abuse and Alcoholism yields new data on anxiety disorders quality of care - Asthma Epidemiology
Researchers from Genentech, Inc. provide details of new studies and findings in the area of asthma epidemiology - Awards
Focus Infomatics receives 2006 Best in KLAS Award, ranked #1 in outsourced transcription - Blood Pressure
The Medicines Company's clevidipine phase 3 safety trials meet pre-specified objectives - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
